Benefits of Combining GLP-1 and SGLT2 Inhibitor Treatment The combination of GLP-1 receptor agonists and SGLT2 inhibitors offers multiple clinical advantages extending beyond glycaemic control
H.KangH
On BPC-157, eight members of the committee voted yes, six voted no, and one abstained
From an ethical perspective, offering BPC157 to patients without robust evidence may violate the principle of first, do no harm. Medical ethicists warn that prescribing the compound outside of an approved trial amounts to experimenting on patients without oversight
A 2021 New England Journal of Medicine study found that combining semaglutide with lifestyle interventions, including exercise, led to an average 14.9% weight loss over 68 weekssignificantly more than lifestyle changes alone
doi:10.1210/jcem.87.4.8421 Zheng H, Wei J, Wang L, et al